DIFFERENCES BETWEEN BLASTIC CHRONIC MYELOID-LEUKEMIA AND PH-POSITIVE ACUTE-LEUKEMIA

被引：32

作者：

BERGER, R

机构：

[1] Institut de Génétique Moléculaire, Paris

来源：

LEUKEMIA & LYMPHOMA | 1993年 / 11卷

关键词：

DIFFERENCES; BLASTIC CML; PH+ALL;

D O I：

10.3109/10428199309047892

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Cytogenetic and molecular characteristics of chronic myeloid leukemia in blast crisis and Ph-positive acute leukemia are compared. The main differences relate to the presence of Ph-negative metaphases at diagnosis and the disappearance of Ph in complete remission in acute leukemia, and the localization of the chromosome breakpoints in the BCR gene, in the bcr segment in chronic leukemia and in the first intron of the BCR gene in 50% of acute leukemias. The profiles of these abnormalities, as well as the types of additional chromosome changes, are not sufficient to distinguish between the two disorders in every patient. The distinction between these two entities, which is possible in the majority of patients, will be improved by results of experimental work currently in progress in many laboratories.

引用

页码：235 / 237

页数：3

共 23 条

[11] Kalousek D.G., Dube I.D., Eaves C.J., Eaves A.C., Cytogenetic studies on haematopoietic colonies from patients with an initial diagnosis of acute lymphoblastic leukaemia, Br. J. Haematol., 70, pp. 5-11, (1988)
[12] Kitano K., Sato Y., Suda T., Miura Y., Difference of cell lineage expression of haematopoietic progenitor cells in Philadelphia-positive acute lymphoblastic leukaemia and chronic myelogenous leukaemia, Br. J. Haematol., 70, pp. 21-26, (1988)
[13] Tachibana N., Raimondi S.C., Lauezr S.J., Sartain P., Dow L.W., Evidence for a multipotent stem cell disease in some childhood Philadelphia chromosome-positive acute lymphoblastic leukemia, Blood, 70, pp. 1458-1461, (1987)
[14] Ponzetto C., Guerrasio A., Rosso C., Avanzi G., Tassinari A., Zaccaria A., LoCoco F., Foa R., Basso G., Abate M.L., Comoglio P.M., Saglio G., ABL proteins in Philadelphia-positive acute leukaemias and chronic myelogenous leukemia blast crisis, Br. J. Haematol., 76, pp. 39-44, (1990)
[15] Birnie G.D., Mills K.I., Benn P., Does the site of the breakpoint on chromosome 22 influence the duration of the chronic phase in chronic myeloid leukemia?, Leukemia, 3, pp. 545-547, (1989)
[16] Selleri L., von Lindern M., Hermans A., Meijer D., Torelli G., Grosveld G., Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia-type 7 kb transcript, Blood, 75, pp. 1146-1153, (1990)
[17] Dhingra K., Talpaz M., Kantarjian H., Ku S., Rothberg J., Gutterman J.U., Kurzrock R., Appearance of acute leukemia-associated P190<sup>BCR ABL</sup> in chronic myelogenous leukemia may correlate with disease progression, Leukemia, 5, pp. 191-195, (1991)
[18] Soekarman D., van Denderen J., Hoefsloot L., Moret M., Meeuwsen T., van Baal J., Hagemeijer A., Grosveld G., A novel variant of the bcr-abl fusion product in Philadelphia chromosome-positive acute lymphoblastic leukemia, Leukemia, 4, pp. 397-403, (1990)
[19] van der Plas D.C., Soekerman D., van gent A.M., Grosveld G., Hagemeijer A., bcr-abl mRNA lacking abl exon a2 detected by polymerase chain reaction in a chronic myelogenous leukemia patient, Leukemia, 5, pp. 457-461, (1991)
[20] Kantarjian H.M., Talpaz M., Dhingra K., Estey E., Keating M.J., Ku J., Trujillo J., Huh Y., Stass S., Kurzrock R., Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia-positive acute leukemia, Blood, 78, pp. 2411-2418, (1991)

← 1 2 3 →